Clinical practice guidelines and real-world practice for hepatocellular carcinoma in Taiwan: Bridging the gap.
作者信息
Wang Shen-Yung
机构信息
Division of Gastroenterology and Hepatology, Department of Medicine, MacKay Memorial Hospital, Taipei, Taiwan.
出版信息
Clin Mol Hepatol. 2023 Apr;29(2):349-351. doi: 10.3350/cmh.2023.0082. Epub 2023 Mar 20.
Abstract
摘要
相似文献
1
Clinical practice guidelines and real-world practice for hepatocellular carcinoma in Taiwan: Bridging the gap.台湾肝细胞癌的临床实践指南与实际临床应用：弥合差距
Clin Mol Hepatol. 2023 Apr;29(2):349-351. doi: 10.3350/cmh.2023.0082. Epub 2023 Mar 20.
2
Challenges in translating clinical guidelines into real-life practice for management of hepatocellular carcinoma in Taiwan.台湾地区将临床指南转化为肝细胞癌实际管理措施面临的挑战。
Clin Mol Hepatol. 2023 Apr;29(2):352-354. doi: 10.3350/cmh.2023.0101. Epub 2023 Mar 20.
3
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.欧洲肝脏研究学会-欧洲肿瘤内科学会临床实践指南：肝细胞癌的管理
Eur J Cancer. 2012 Mar;48(5):599-641. doi: 10.1016/j.ejca.2011.12.021.
4
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.欧洲肝脏研究学会-欧洲肿瘤内科学会临床实践指南：肝细胞癌的管理
J Hepatol. 2012 Apr;56(4):908-43. doi: 10.1016/j.jhep.2011.12.001.
5
[Guidelines for diagnosis and treatment of primary liver cancer in China (2019 edition)].《中国原发性肝癌诊疗规范（2019年版）》
Zhonghua Gan Zang Bing Za Zhi. 2020 Feb 20;28(2):112-128. doi: 10.3760/cma.j.issn.1007-3418.2020.02.004.
6
Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up.肝细胞癌：ESMO-ESDO诊断、治疗及随访临床实践指南
Ann Oncol. 2012 Oct;23 Suppl 7:vii41-8. doi: 10.1093/annonc/mds225.
7
[Diagnostic imaging and therapy of hepatocellular carcinoma].[肝细胞癌的诊断成像与治疗]
Dtsch Med Wochenschr. 1997 Dec 12;122(50):1573-5.
8
Toward user-friendly and evidence-based practice guidelines for hepatocellular carcinoma.迈向用户友好型和基于证据的肝细胞癌实践指南
Clin Mol Hepatol. 2023 Apr;29(2):335-338. doi: 10.3350/cmh.2023.0107. Epub 2023 Mar 20.
9
Hepatocellular carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.肝细胞癌：ESMO关于诊断、治疗及随访的临床建议
Ann Oncol. 2008 May;19 Suppl 2:ii27-8. doi: 10.1093/annonc/mdn114.
本文引用的文献
1
Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Taiwan perspective.肝细胞癌的临床实践指南和实际实践：台湾视角。
Clin Mol Hepatol. 2023 Apr;29(2):230-241. doi: 10.3350/cmh.2022.0421. Epub 2023 Jan 30.
2
Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease.全国性肝细胞癌监测对慢性肝病患者预后的影响。
Clin Mol Hepatol. 2022 Oct;28(4):851-863. doi: 10.3350/cmh.2022.0037. Epub 2022 Jun 3.
3
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma.2022 KLCA-NCC 韩国肝细胞癌管理实践指南。
Clin Mol Hepatol. 2022 Oct;28(4):583-705. doi: 10.3350/cmh.2022.0294. Epub 2022 Oct 1.
4
Surveillance for hepatocellular carcinoma: It is time to move forward.肝细胞癌监测：是时候向前迈进了。
Clin Mol Hepatol. 2022 Oct;28(4):810-813. doi: 10.3350/cmh.2022.0257. Epub 2022 Sep 6.
5
The best predictive model for hepatocellular carcinoma in patients with chronic hepatitis B infection.乙型肝炎感染患者肝细胞癌的最佳预测模型。
Clin Mol Hepatol. 2022 Jul;28(3):351-361. doi: 10.3350/cmh.2021.0281. Epub 2021 Nov 26.
6
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update.BCLC 策略用于预后预测和治疗推荐：2022 年更新版。
J Hepatol. 2022 Mar;76(3):681-693. doi: 10.1016/j.jhep.2021.11.018. Epub 2021 Nov 19.
7
Systemic treatment of hepatocellular carcinoma: An EASL position paper.肝细胞癌的全身治疗：一篇欧洲肝脏研究学会立场文件。
J Hepatol. 2021 Oct;75(4):960-974. doi: 10.1016/j.jhep.2021.07.004. Epub 2021 Jul 10.
8
Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update.日本肝细胞癌的管理：2021年更新版日本肝脏学会共识声明与建议
Liver Cancer. 2021 Jun;10(3):181-223. doi: 10.1159/000514174. Epub 2021 May 19.
9
Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan.台湾肝癌医学会与台湾消化系医学会之肝细胞癌管理共识指引：2020 年更新版-监控、诊断与全身性治疗
J Formos Med Assoc. 2021 Apr;120(4):1051-1060. doi: 10.1016/j.jfma.2020.10.031. Epub 2020 Nov 14.
10
Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma.免疫检查点抑制剂联合治疗肝细胞癌的挑战。
J Hepatol. 2020 Feb;72(2):307-319. doi: 10.1016/j.jhep.2019.09.025.
Zotero 插件